BioTech Mag Search: Biotech
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries
Genfit is halting all work on its lead drug in the fatty liver disorder nonalcoholic steatohepatitis and implementing a corporate restructuring that will cut 40 percent of its...
9 hours ago - Xconomy
Inventory Control Analyst
Outstanding Biotech company seeks candidate to be responsible for planning inventory quantity based on manufacturing supply demand. Important to come from a technical field...
12 hours ago - San Diego Biotechnology - 3 articles
Procurement Manager
Outstanding Biotech company seeks to fill role of Procurement Manager to manage the companyâ??s supply of products and services. *Must come from Diagnostics! Will hit the...
12 hours ago - San Diego Biotechnology - 3 articles
Supply Chain Manager
Outstanding Biotech company seeks candidate to hit the ground running and lead the Supply Chain Team. *Must come from Diagnostics industry! This role is responsible for...
12 hours ago - San Diego Biotechnology - 3 articles
AXIM® Biotechnologies Files Patent for Virus Binding Recombinant Protein for SARS-CoV-2 and Begins Manufacturing
SAN DIEGO, Sept. 30, 2020 - AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and...
13 hours ago - San Diego Biotechnology - 2 articles
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
19 hours ago - Xconomy - 2 articles
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China
CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing a bet on that promise by...
19 hours ago - Xconomy
Animal Biotech Online Discourses Cover Genome Editing Regulatory Approaches
Session 2 of the 4th International Workshop on Regulatory Approaches for Animal Biotechnology was successfully held on September 23 to 24, 2020, with around 167 participants...
19 hours ago - ISAAA
RNAi trailblazer Alnylam teases more positive data for a potential third commercial drug
RNAi pioneer Alnylam snagged its first and second FDA approvals in the last two years. And on Wednesday, the Cambridge, MA-based biotech announced it has more positive data to...
20 hours ago - San Diego Biotechnology - 2 articles
Micronoma Appoints Magda Marquet Chairman of the Board
Biotech maven joins early-stage cancer detection company utilizing innovative microbiome analysis SAN DIEGO, Sept. 30, 2020 /PRNewswire/ - Micronoma, an early stage...
23 hours ago - San Diego Biotechnology
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Scientists Capture Candid Snapshots of Electrons Harvesting Light at the...
A research team led by Berkeley Lab has gained important new insight into electrons' role in the harvesting of light for solar fuels. In the search for clean energy...
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries
Genfit is halting all work on its lead drug in the fatty liver disorder nonalcoholic steatohepatitis and implementing a corporate restructuring that will cut 40 percent of its...
Synthetic Pathways Turn Plants into Biofactories for New Molecules
Plants can produce a wide range of molecules, many of which help them fight off harmful pests and pathogens. Biologists have harnessed this ability to produce many molecules...
Transforming Waste into Bio-Based Chemicals
Researchers at Berkeley Lab have transformed lignin, a waste product of the paper industry, into a precursor for a useful chemical with a wide range of potential...
Providing New Technologies for Vaccine Development
Credit: Design Cells/Shutterstock Vaccines, which help the body recognize infectious microorganisms and stage a stronger and faster response, are made up of proteins that are...
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China
CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing a bet on that promise by...
New Research Provides Clues on Optimizing Cell Defenses When Viruses Attack
UC San Diego scientists are providing new clues on how cells defend themselves from attack from viruses. The new study advance's science's understanding of interferons...
Kawasaki Disease is not a Homogenous Disease nor are its Triggers
Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters. ...
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins
Orphazyme has fresh cash from the sale of shares in the US and Europe, which will support its lead rare disease drug through regulatory review and, if approved, a launch. But...